11 results · 23ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

MILAGRO Interference Screw; MILAGRO ADVANCE Interference Screw

FDA 510(k)
FDA Class 2 ·Orthopedic

VERTE-STACK® Spinal System

FDA UDI
MEDTRONIC SOFAMOR DANEK, INC.·00613994305152·IMPLANT 6240441 ANATOMIC 14X11X14MM

ANATOMIC PEEK CERVICAL FUSION SYSTEM

FDA UDI
MEDTRONIC SOFAMOR DANEK, INC.·00613994360564·IMPLANT 4240441 ANATOMIC C 14X11X 14MM

BI-FLEX URETERAL ACCESS SHEATH

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

UroLift Advanced Tissue Control (ATC) System

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

ALARIS SYSTEM

FDA Adverse Event
Malfunction ·CAREFUSION SD·Product code FRN·October 27, 2023

TENDRIL ST

FDA Adverse Event
Injury ·ST JUDE MEDICAL CARDIAC RHYTHM MANAGEMENT DIVISION·Product code NVN·September 9, 2011

*

FDA Adverse Event
Other ·*·Product code BTG·August 14, 2008

2MM COARST DIAMOND BALL, STD

FDA Adverse Event
Malfunction ·DEPUY SYNTHES POWER TOOLS·Product code HBC·July 17, 2013

Model Number L111, ESSENTIO DR SL MRI Pacemaker

FDA Enforcement
Class I ·Ongoing·Boston Scientific Corporation·October 22, 2025

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014